COVID-2019 Alert

The latest information about the 2019 Novel Coronavirus, including vaccine clinics for children ages 6 months and older.

La información más reciente sobre el nuevo Coronavirus de 2019, incluidas las clínicas de vacunación para niños de 6 meses en adelante.

  • Hayden on scooterHayden on scooter
  • Doctor with babyDoctor with baby
  • Ben having fun and making jumpsBen having fun and making jumps
  • Hematology Condition BannerHematology Condition Banner
  • hematology research bannerhematology research banner

Stanford Cancer Institute logo

Pediatric Hematology

U.S. News & World Report - CancerIf your child is diagnosed with a blood disorder or disease, you’ll need a trusted partner to deliver a lifetime of the highest quality, cutting-edge care.

Our team of experts work together to care for infants, children, and young adults. We provide exceptional care and the latest treatments while studying new therapies to improve our patients’ quality of life and cure lifelong blood diseases. From your child’s first visit, we will work with your family to develop a care plan tailored to your child’s unique needs.

Our hematology program is part of the Bass Center for Childhood Cancer and Blood Diseases, which is nationally ranked by U.S. News & World Report and part of the NCI-designated Stanford Cancer Institute.

We see more hematology patients than many children’s hospitals in the country. For decades, we’ve been at the forefront of patient care and groundbreaking research for blood diseases. Our doctors are faculty members of the world-class Stanford University School of Medicine, and we are dedicated to helping you understand your child’s condition so you can make well-informed decisions about your child’s care.

To bring new treatments to our patients, we conduct research related to every condition we treat, including:

  • Testing the use of a new gene-editing technique to insert a working copy of missing blood-clotting factors into the DNA of patients with hemophilia.
  • Exploring the use of gene editing to replace the mutated gene that causes sickle cell disease with a healthy copy.
  • Investigating the impacts of new drugs on hemolytic anemia and Diamond–Blackfan anemia.
  • Studying the ideal duration of anti-clotting therapy in children with blood clots.

Please call (650) 502-7028 for appointments and more information.